| Prev Close: | 32.16 |
|---|---|
| Open: | 32.19 |
| Bid: | 32.29 x 300 |
| Ask: | 32.32 x 100 |
| 1y Target Est: | 38.35 |
| Beta: | 1.35 |
| Next Earnings Date: | 29-Jul-13 |
| Day's Range: | 31.74 - 32.37 |
|---|---|
| 52wk Range: | 21.26 - 40.87 |
| Volume: | 199,452 |
| Avg Vol (3m): | 457,389 |
| Market Cap: | 1.29B |
| P/E (ttm): | 8.90 |
| EPS (ttm): | 3.63 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- CORRECTING and REPLACING Acorda Therapeutics Announces Publication of New Data on Impact of Mobility Impairment Due to Multiple SclerosisBusiness Wire(Tue 12:45PM EDT)
- InPlay: Acorda Therapeutics announces publication of new data on impact of mobility impairment due to multiple sclerosisBriefing.com(Tue 8:11AM EDT)
- ACORDA THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Tue 1:37AM EDT)
- 4 Healthcare Stock Stories Prescribed For Investorsat Wall St. Cheat Sheet(Mon May 20)
- Acorda Therapeutics Announces Issuance of Additional U.S. Patent for AMPYRA® Covering a Range of Dosage StrengthsBusiness Wire(Mon May 20)
- ACORDA THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Mon May 20)
- ACORDA THERAPEUTICS INC FinancialsEDGAR Online Financials(Fri May 17)
- Acorda Therapeutics’ Legal Department Recognized on Best Legal Departments List by Corporate Counsel MagazineBusiness Wire(Fri May 17)
- Acorda Therapeutics to Present at the UBS Global Healthcare ConferenceBusiness Wire(Wed May 15)
- ACORDA THERAPEUTICS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri May 10)
- Acorda says data support initiation of current dalfampridine development programtheflyonthewall.com(Thu May 9)
- Acorda Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care ConferenceBusiness Wire(Thu May 9)
- Acorda Therapeutics Announces Data Showing Dalfampridine Improves Motor Function in Preclinical Model of Post-Stroke Deficits Published in StrokeBusiness Wire(Thu May 9)
- ACORDA THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Thu May 9)
- Acorda Incurs Loss, Maintains GuidanceZacks(Mon May 6)
Press Releases
- CORRECTING and REPLACING Acorda Therapeutics Announces Publication of New Data on Impact of Mobility Impairment Due to Multiple SclerosisBusiness Wire(Tue 12:45PM EDT)
- Acorda Therapeutics Announces Issuance of Additional U.S. Patent for AMPYRA® Covering a Range of Dosage StrengthsBusiness Wire(Mon May 20)
- Acorda Therapeutics’ Legal Department Recognized on Best Legal Departments List by Corporate Counsel MagazineBusiness Wire(Fri May 17)
Must Read
- Carney to Europe: Learn from Japan the dangers of half measuresReuters(1969-12-31T18:59:59GMT-05:00)
- Exclusive: Intel CEO shakes up units, creates "new devices" group - sourceReuters(1969-12-31T18:59:59GMT-05:00)
- Dirt containment wall built when oil leaks after Saskatchewan train derailmentThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Sprint raises Clearwire offer, not enough for someReuters(1969-12-31T18:59:59GMT-05:00)
- Loonie rises ahead of monetary policy speeches by U.S. Federal Reserve, BoCThe Canadian Press(1969-12-31T18:59:59GMT-05:00)